Structural Formula For Carvedilol (Image 1)
Carvedilol Tablet, Film Coated
Product Images NDC 82804-138
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 82804-138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fig 1 (Image 2)
This text provides information on mortality rates between the placebo group and the group treated with Carvedilol, indicating a significant difference (P=0.0014). The mortality rates seem to be 3% for placebo and possibly escalating numbers for Carvedilol. The data suggests that Carvedilol might impact mortality rates.*
Fig 2 (Image 3)
Fig 3 (Image 4)
This is a chart showing the mortality rates over a span of 24 months for patients taking a placebo versus patients taking Carvedilol. The data indicates the percentage of mortality at different time intervals. This data can be used to evaluate the effectiveness of Carvedilol in reducing mortality compared to a placebo in the given timeframe.*
Fig 4 (Image 5)
82804-138-90 (Image 9)
This is a description of Carvedilol 25mg tablets, packaged by Proficient Rx LP. Each tablet contains 25mg of carvedilol, USP, and is film-coated. The tablets are white, elliptical-shaped, and embossed with "TV" on one side and "7296" on the other. The product is intended for Rx use only. The tablets should be stored at 20°-25°C (68°-77°F) and kept out of reach of children. The NDC number for this medication is 82804-138-90.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
